The Philips Healthcare Stellarex drug-coated balloon (DCB). It is cleared for use in peripheral vessels and treatment of failing AV access.
Feature | Drug-Eluting Balloons | Dave Fornell, Editor

Drug-coated balloons (DCB), also referred to as drug-eluting balloons (DEB), were created as a way to reduce very high ...

Home August 06, 2020
Home
News | Left Atrial Appendage (LAA) Occluders

August 6, 2020 – Conformal Medical Inc. announced it secured $85 million in Series C financing to support the company’s ...

Home August 06, 2020
Home
News | Heart Valve Technology

August 5, 2020 – Minneapolis-based CardioMech AS, a medical device company developing a transfemoral, transseptally ...

Home August 05, 2020
Home
News | Remote Monitoring

August 5, 2020 – NorthShore University HealthSystem , Carnegie Mellon University and physIQ are collaborating on a multi ...

Home August 05, 2020
Home
Abiomed Impella is now authorized to treat critical ICU COVID-19 patients on ECMO who develop pulmonary edema or need cardiac decompensation from myocarditis. #COVID19 #SARScov2 #Impella
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

August 5, 2020 — The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) this week for ...

Home August 05, 2020
Home
News | Cardiovascular Ultrasound

August 4, 2020 — Imaging software company TomTec has released its new TomTec-Arena 2020 product, which offers new ...

Home August 04, 2020
Home
News | Atrial Fibrillation

August 4, 2020 — Abbott announced the first enrollments in the TactiFlex PAF investigational device exemption (IDE) ...

Home August 04, 2020
Home
News | Heart Failure

August 4, 2020 - More than three years after a clinical trial was prematurely ended for failing to show progress in ...

Home August 04, 2020
Home
News | Cardiogenic Shock

August 3, 2020 — A three-year, investigator-led, prospective study of Japanese patients who received an Impella heart ...

Home August 03, 2020
Home
Two of the top pieces of content in July included the FDA clearance for the new Watchman FLX left atrial appendage occluder (left), which includes a video interview with one of the trial investigators. COVID-19 content remained among the top content in July, and one story explained the odd pattern of cardiac cell death in COVID-19 patient autopsies. 
Feature | Dave Fornell, Editor

August 3, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home August 03, 2020
Home
Videos | TCT

With COVID-19 forcing all medical conferences to go virtual in 2020, Juan F. Granada, M.D., CEO of the Cardiovascular ...

Home August 01, 2020
Home
An example of perivascular fat attenuation index (FAI) imaging inside the coronary vascular wall to show areas of inflammation. #SCCT2020
Feature | CT Angiography (CTA) | Dave Fornell, Editor

There is a promising recent development in cardiovascular computed tomography angiography (CCTA) to analyze plaque to ...

Home July 30, 2020
Home
Left, a 3-D rendering of a heart from a cardiac CT exam. Right, a lung-CT exam showing the heart and ground glass lesions in the lungs of a COVID-19 patient. CT has become a front-line imaging modality in the COVID era because it offers both cardiac and lung information to help determine a patients disposition with chest pain, COVID-19 and COVID-caused myocarditis and pulmonary embolism.
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

July 28, 2020 — The use of cardiovascular computed tomography angiography (CCTA) is one of the areas that has seen a ...

Home July 28, 2020
Home
Videos | EP Lab

Devi G. Nair, M.D., FHRS, director of cardiac electrophysiology, St. Bernards Heart and Vascular Center, Jonesboro, Ark ...

Home July 28, 2020
Home
News | Pharmaceuticals

July 28, 2020 — AstraZeneca's heart failure medication dapagliflozin (Farxiga) significantly reduced the worsening of ...

Home July 28, 2020
Home
Subscribe Now